TLR4 and metabolic dysfunction-associated steatohepatitis: Several studies have shown that TLR4 signaling is involved in the pathogenesis of various liver diseases, such as alcoholic liver disease (ALD), non-alcoholic steatohepatitis (NASH) and chronic hepatitis C [4–6].